Wednesday, April 19, 2017

Ethicon receives FDA Clearance for its ECHELON CIRCULAR™ PowerEd Stapler.

CINCINNATI, April 19, 2017, Johnson & Johnson subsidiary Ethicon today received FDA 510(k) clearance for its Echelon circular powered stapler.

The ECHELON CIRCULAR™ Powered Stapler is equipped with 2 new technologies that enables it to reduce leaks without compromising circulation of the targeted organ.

Through proprietary Gripping Surface Technology, it is better able to hold the tissues with 33% reduction is tissue trauma. The second technology is 3D Stapling Technology which evenly distributes compression throughout the anastomosis.

A study showed 61% fewer leaks at the staple line compared to Medtronic's DST Series™ EEA™ Stapler.

"Ethicon is committed to reducing complications, which have a significant impact on healthcare costs and patient outcomes," says Tom O'Brien, Vice President, Global Endomechanical Platform Leader.

 "The ECHELON CIRCULAR™ Powered Stapler addresses these challenges by combining powered firing with two staple forming innovations that reduce leaks without compromising perfusion.”

The circular anastomosis is a very decisive step for the success of cancer surgery, that already have high risk of complications because of friability of the tissue. The most dreaded complication is leak which can lead to repeat surgery of the patient with high morbidity and insurance cost.

The circular stapler will specially improve results of bariatric and  colorectal, gastric and thoracic cancer surgeries.


No comments:

Post a Comment